EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • December 22nd, 2020 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 22nd, 2020 Company Industry JurisdictionThis EXECUTIVE SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this ___ day of _____________, ____ (the “Effective Date”) between (“Executive”) and SUNESIS PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 5.
EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • August 11th, 2020 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledAugust 11th, 2020 Company Industry JurisdictionThis Executive Severance Benefits Agreement (the “Agreement”) is entered into this 4th day of May, 2020 (the “Effective Date”) between Constantina Gullotta (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 5.
EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • March 9th, 2018 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 9th, 2018 Company Industry JurisdictionThis Executive Severance Benefits Agreement (the “Agreement”) is entered into this 30th day of November, 2017 (the “Effective Date”) between William P. Quinn (“Executive”) and Sunesis Pharmaceuticals, Inc. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 5.
EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • March 6th, 2014 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2014 Company Industry JurisdictionThis EXECUTIVE SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 6th day of March, 2014 (the “Effective Date”), between JOSEPH DEPINTO (“Executive”) and SUNESIS PHARMACEUTICALS, INC. This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 5.
EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • March 14th, 2012 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 14th, 2012 Company Industry JurisdictionThis EXECUTIVE SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this 31st day of January, 2012 (the “Effective Date”), between ADAM R. CRAIG (“Executive”) and SUNESIS PHARMACEUTICALS, INC. This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 5.